Why Is CASTLE BIOSCIENCES I (CSTL) Stock Moving Today?
CASTLE BIOSCIENCES I (CSTL) is drawing unusual attention today. Our newswire has captured 2 stories on CSTL across 2 sources in the last 36 hours, with AI sentiment reading bullish (avg 63/100).
The written analysis for CSTL publishes to the public page once it clears the 4-hour delay. The coverage, sentiment and session data below are already here.
CSTL by the numbers
The headlines behind the move
New Study Shows That TissueCypher® Changed Management at an Expert Surgery Center in 90% of Patients With Non-Dysplastic Barrett's Esophagus
FRIENDSWOOD, Texas, Sept. 28, 2026 /PRNewswire/ -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the publication of a study showing that its TissueCypher® Barrett's Esophagus Test helped guide...
Frequently asked questions
Why is CSTL stock moving today?
CASTLE BIOSCIENCES I (CSTL) is drawing unusual attention today. Our newswire has captured 2 stories on CSTL across 2 sources in the last 36 hours, with AI sentiment reading bullish (avg 63/100). The most recent driver: "Castle Biosciences: Study shows TissueCypher test changed management" (The Fly).
Is CSTL a buy right now?
Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of CSTL coverage reads 63/100 over 2 stories; treat it as a research signal and do your own diligence.
How fast does this page update?
The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.
More moves explained today
- Why is QURE down today (-39.81%)
- Why is IOVA up today (+27.21%)
- Why is FICO down today (-26.57%)
- Why is PWP up today (+16.53%)
- Why is BE up today (+13.11%)
- Why is CCL up today (+12.62%)
More on CSTL: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.